Elite Pharmaceuticals, Inc. Sustainability Profile
Elite Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development and manufacturing of niche generic and branded pharmaceuticals, particularly in the areas of controlled substances and complex formulations. With a focus on innovative drug delivery systems, Elite Pharmaceuticals offers unique products that cater to unmet medical needs, setting them apart in a competitive market. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and a robust pipeline of products in various stages of development. Recognised for its commitment to quality and compliance, Elite Pharmaceuticals continues to strengthen its market position, contributing to the advancement of healthcare solutions both domestically and internationally.
DitchCarbon Score
How does Elite Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elite Pharmaceuticals, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elite Pharmaceuticals, Inc.'s reported carbon emissions
Elite Pharmaceuticals, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions or reduction initiatives reported, it is unclear how Elite Pharmaceuticals is addressing climate change within its operations. The lack of data may reflect a broader industry context where many companies are still developing their sustainability strategies. Without specific commitments or targets, the company's climate impact remains undefined.
How Carbon Intensive is Elite Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is Elite Pharmaceuticals, Inc.'s Location?
Elite Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elite Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
